Renal transplantation outcomes in obese patients: a French cohort-based study.

BACKGROUND: Whilst there are a number of publications comparing the relationship between body mass index (BMI) of kidney transplant recipients and graft/patient survival, no study has assessed this for a French patient cohort. METHODS: In this study, cause-specific Cox models were used to study patient and graft survival and several other time-to-event measures. Logistic regressions were performed to study surgical complications at 30 days post-transplantation as well as delayed graft function. RESULTS: Among the 4691 included patients, 747 patients were considered obese with a BMI level greater than 30 kg/m2. We observed a higher mortality for obese recipients (HR = 1.37, p = 0.0086) and higher risks of serious bacterial infections (HR = 1.24, p = 0.0006) and cardiac complications (HR = 1.45, p < 0.0001). We observed a trend towards death censored graft survival (HR = 1.22, p = 0.0666) and no significant increased risk of early surgical complications. CONCLUSIONS: We showed that obesity increased the risk of death and serious bacterial infections and cardiac complications in obese French kidney transplant recipients. Further epidemiologic studies aiming to compare obese recipients versus obese candidates remaining on dialysis are needed to improve the guidelines for obese patient transplant allocation.

[Acute renal failure of the donor in encephalic death: A real contraindication to kidney transplantation?] / L'insuffisance rénale aiguë du donneur en mort encéphalique : une réelle contre-indication à la transplantation rénale ?

INTRODUCTION: The shortage of kidney transplants encourages the expansion of the limits of eligibility criteria for donation. Many donors who are brain dead display acute renal failure at the time of death; is this a real contraindication to harvesting? The aim of this study was to assess kidney graft survival from donors after brain death with confirmed acute renal failure, with or without anuria previous donation. MATERIALS AND METHODS: All of the transplants performed in two university hospitals between 2010 and 2017 were analyzed retrospectively. All patients who underwent single kidney transplant from a brain-dead donor with acute renal failure (ARF) were included in this study. ARI was defined here by a decrease over 50 % of glomerular filtration rate (GFR) to a threshold below 45mL/min/1.73 m2 at the time of kidney procurement. Kidney graft survival, incidence of delayed graft function (DGF) and the GFR at 12 months were analyzed. Analysis of kidney transplant survival based on pre-implantation biopsies was additionally done. RESULTS: One hundred and sixty four patients were transplanted with a kidney from donor with ARF during the selected period. At the admission in ICU the average GFR was 67,7±19mL/min/1,73m2. At the time of donation, the average age of donors was 56.4±17.7 years, the GFR was 33.7±8.0mL/min/1.73 m2 16 % of donors were anuric. Cold ischemia time (CIT) was 16.8±5.0hours. The average age of recipients was 55.6±14.1 years. 81 % of the cases were primary transplants. Graft function took place within 7.8±9.4 days after transplantation. There were two non-primary functions (PNF). One hundred and fifty two patients (93 %) had a functional graft at 12 months. The mean GFR at 12 months was 46.8±20.1mL/min/1.73 m2 and 122 patients (73 %) had a GFR greater than 30mL/min/1.73 m2. Seventy-one percent of preimplantation biopsies revealed acute tubular necrosis (ATU); no cortical necrosis was observed. Survival of theses grafts was 85 %, comparable to the total population of study (P=0,21) CONCLUSION: The acute renal failure of the brain-dead donor should not alone be systematically a contraindication to harvesting and kidney transplantation.

Image resolution and magnification using a cone beam densitometer: optimizing data acquisition for hip morphometric analysis.

Bone mineral density (BMD) is a primary determinant of hip fracture risk. However, other factors, notably the femoral geometry, can influence hip fracture risk. The purpose of this study was to evaluate the potential of a new cone beam densitometer, the DMS Lexxos, in order to visualise femoral morphometry. Resolution, magnification and distortion were assessed in vitro using a line pair test pattern and a matrix test object. Results were given in comparison with currently available systems: the Hologic Discovery A and the Lunar Prodigy densitometers. The DMS Lexxos image resolution was the same in the longitudinal and transversal directions evaluated between 1.4 and 0.5 line pairs/mm (lps/mm) for an attenuation varying from 25 to 325 mm of Perplex. The longitudinal resolution was evaluated between 0.9 and 0.5 lps/mm with the Hologic Discovery densitometer, and inferior to 0.5 with the Lunar Prodigy; as for transversal resolution, it varied from 0.63 to 0.5 lps/mm and from 0.6 to inferior 0.5 lps/mm, respectively. The image was isotropic without magnification with the GE-Lunar Prodigy, whereas there was only a transversal magnification with the Hologic Discovery device. The magnification was about 1.17% cm(-1 )in the two directions, while increasing the distance of the phantom above the examination table with the Lexxos. This magnification was isotropic without distortion. The magnification could be evaluated from two images taken before and after translation of the C-arm, and a magnification correction could be applied. This method was applied to a phantom and to a human cadaver femoral bone.